Exposure to TNF inhibitors is rare at MOGAD presentation

Zara P.;Cauli A.;Solla P.;Sechi E.
2022-01-01
2022
2021
Inglese
432
120044
3
2-s2.0-85122148335
34728073
Esperti anonimi
scientifica
Adverse event; Demyelination; MOGAD; Myelin oligodendrocyte glycoprotein; Tumor necrosis factor
sì
Redenbaugh, V.; Flanagan, E. P.; Floris, V.; Zara, P.; Bhatti, M. T.; Sanchez, F.; Koster, M.; Mariotto, S.; Pittock, S. J.; Chen, J. J.; Cauli, A.; S ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
13
reserved
Files in This Item:
File Size Format  
PDF CAULI 1-s2.0-S0022510X21027465-main.pdf

Solo gestori archivio

Type: versione editoriale
Size 484.79 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
484.79 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie